Personalized therapy is related to the genetic makeup of a person. It helps doctors to understand how a tumor grows in a particular patient to identify effective screening, control, and treatment methods. : Doctors are engaged in developing novel treatments with fewer side effects as compared to the traditional treatments. Doctors perform various genetic tests on cancer cells and on normal cells, to develop new customized treatment according to the patient’s needs.
Before personalized therapy, most patients with a specific stage and type of cancer received similar treatment. However, it is evident that certain treatments work specifically on some patients and give better results, as compare to other patients. Development in the field of genetics has led scientists to identify genetic differences in certain patients and their cancer, this described several other responses to treatment. A cancer patient can obtain a standard treatment strategy, such as tumor removal. The doctors can prescribed a personalized cancer treatment. Personalized therapy is an important part of cancer treatment or a part of the clinical trial. A clinical trial is an investigation study including people.
Targeted cancer treatment targets specific genes and proteins that allow cancer cells to survive and grow. Research scientists are continuously identifying new targets each year. They develop and test new medicines for these new targets. Targeted therapy is used for lung cancer, kidney cancer, gastrointestinal stromal tumor, colorectal cancer, and breast cancer, among others. For the treatment of cancer by targeted therapy, it is very important to find out whether the tumor has specific target or not, and this can be identify by the testing of the tumor sample.
Therapy that targets definite mutant genes, have been existing for few type of cancers since 2001, and by the several studies researchers determined that which tumors will respond best with which drug. For example, changes in the epidermal growth factor receptor (EGFR) gene that affects the response of patient, suffering with lung cancer when the medicine target the EGFR protein. However, recent studies have indicated the shortcomings of targeted therapy by highlighting that the genetic origins of several cancers are both complex and unclear. An extensive diversity of rare mutations can give rise to any type of cancer and mutations in the similar genetic pathways arise in several types of tumors. Rise in the prevalence of cancer, across the world, growing awareness about existing treatments available in the market, and an increasing directness toward the acceptance of promising innovative treatment procedures are key factor driving the global personalized cancer therapy market. The market is also driven by substantial developments in gene sequencing methods and high accuracy in its results.
The global personalized cancer therapy market has been segmented into application, technique, technology, and geography. In terms of technique, the global personalized cancer therapy market has been classified into genomics, proteomics, epigenetics, and metabolomics. Based on technology, the market has been segmented into immunohistochemistry, in situ hybridization (ISH), quantitative PCR, next-generation sequencing, and microarray. In terms of application the global personalized cancer therapy market has been categorized into personalized medicines, biomarker discoveries, diagnostics, prognostics, and research applications. Based on geography, the global personalized cancer therapy market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Key players operating in the global personalized cancer therapy market include Illumina Inc., QIAGEN N.V., NeoGenomics Laboratories, HTG Molecular Diagnostic, and Genomic Health Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.